| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,340,000 | 2,096,000 | 1,638,000 | 1,537,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 2,096,000 | 1,638,000 | 1,537,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 741,000 | 1,585,000 | 1,593,000 | 1,656,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,179,000 | 349,000 | 349,000 | 384,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 325,000 | 162,000 | (304,000) | (503,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 420,000 | 162,000 | (304,000) | (503,000) | | Interest Expense | 34,000 | 30,000 | 31,000 | 34,000 | | Income Before Tax | 386,000 | 132,000 | (335,000) | (537,000) | | Income Tax Expense | 108,000 | 12,000 | (150,000) | (219,000) | | Minority Interest | (38,000) |
-
|
-
| (17,000) | | | | Net Income From Continuing Ops | 278,000 | 120,000 | (185,000) | (335,000) | | | Non-recurring Events | | Discontinued Operations | (1,000) | (1,000) |
-
| (1,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 239,000 | 119,000 | (185,000) | (336,000) | | Preferred Stock And Other Adjustments | (70,000) | (14,000) | (10,000) |
-
| | | Net Income Applicable To Common Shares | $169,000 | $105,000 | ($195,000) | ($336,000) |
|
0.04% Nasdaq 
0.64%
Income Statement
